Volume surge masks profit stall; margin recovery deferred to H2

CV volume peak confirmed (+15% MHCV, +21% LCV). Consolidated PAT only +1.5% YoY despite 13–17% industry growth. EBITDA flat.

CV business ₹9,634 Cr matches claim. Consolidated revenue ₹13,069.6 Cr (includes ₹3,436 Cr non-CV). EBITDA ₹970 Cr verified.

Price: 1.25% in Q1, cumulative 2.25% MHCV YTD. Inventory accounting deferred ~20–25% of cost inflation to future periods. Material cost 71.5% of revenue (+90 bps YoY despite claims of offset).

Management cited ₹609 Cr PAT (CV only); consolidated PAT ₹667.8 Cr is +1.5% YoY. Core profit growth significantly weaker than volume growth.

Management stated June industry growth >20%, July >20%, August sentiment positive. Corroborated by Q1 industry +13% despite May disruption.

Management disclosed 6,500→8,500 vehicles in inventory buffer, using 20–25% of Q1 costs from opening stock. This is new disclosure; prior calls didn't quantify this mechanism.

Prior calls promised 'temporary' compression; this call specifies Q2 as peak pressure month, Q3 softening (not prior calls). Expectation reset downward on timing.

GCC disruption (war/logistics) cost ₹18% of export volume in Q1. Management now expects recovery but admits wholesale stock losses. Near-term GCC assumption revised.

Shifted from 2–3.5 ton focus to full VAHAN market. Gained 30 bps share to 13.2%. New products in pipeline. Market share expansion narrative strengthened.

1.2–1.25% price taken in Q1. Opening inventory provided 20–25% of Q1 costs at lower prices; remaining cost inflation added to closing inventory (8,500 vs 6,500 vehicles). Q2 will see reversal impact but magnitude unquantified. Additional price increases taken July onwards.

Commodity costs will be higher in Q2 than Q1. Mix shift to HIPPO/TAURUS (higher margin), air suspension trucks, and higher non-MHCV (Defense/PSB) orders can help offset. Price increases from July 1, possibly more before quarter end. But exact Q2 margin situation cannot be told at this time.

We rely on supplier feedback, SIAM reports, CRISIL reports. Q2 should be peak; Q3 some softening; Q4 turnaround. But final visibility is supplier-dependent and macro-dependent.

Very confident industry will grow through October. High base issue post-October (20–21% growth last year). Conservative outlook for Oct–Dec, but even so, expect high-single-digit growth H2. LCV outlook slightly better.

Historically focused on 2–3.5 tons. Now targeting full VAHAN market via Saathi product (premium sub-2-ton) and new pipeline products. Currently participate in 50% of LCV market; headroom exists for full range. Q1 gained 30 bps VAHAN share to 13.2% via quarter-on-quarter gains.

GST 2.0 optimization was the trigger. It changed TCO economics of BS6 vs BS3/BS4 trucks, making replacement economically compelling. Combined with interest rates, finance availability, infrastructure uptick. Replacement cycle will continue many quarters to absorb BS2–BS4 fleet.

RAK plant disrupted in Apr–May due to war/logistics. Now ramping 600→700→800 units/month (capacity 600, running at 800 with temp arrangements). No retail loss in GCC, only wholesale stock reduction. SAARC/Africa +40–60% offsetting. New Saudi plant construction accelerating. GCC recovery path clear.

Regulatory burden high on CV industry. Challenge is meeting regulations while creating TCO value for customers. AC mandate precedent: customers accept price increases if TCO is positive. BS7 not before 2031, possibly 2032. Industry and company working on valuations and implementation.

Key strategy: non-MHCV domestic business to cover 100% fixed cost (target achieved: 1,000–1,500 units/month breakeven vs 6,000–7,000 prior). Reduces cyclical dependency. Defense, Aftermarket, EVs, Power Solutions have aggressive plans and better margins. Detailed breakdown not provided.

No. This is premiumization strategy aligned with company philosophy. Competitor product launched 3–4 months ago; company developed air suspension solution 2.5–3 years ago in response to same need. Air suspension offers 4-ton payload vs competitor's 2-ton, better engineered. Not a knee-jerk response; differentiated value. Innovation pipeline robust.

No production issue. Bus market split: heavy-duty (1/3, Ashok 60–80% historic share), medium-sized (2/3, Ashok was 15%, now 25% post-4 years). Strategy: reject unprofitable heavy-duty tenders; focus medium-sized private/school segment. Q1 share loss was deliberate (unprofitable tenders declined).

Q1 industry +13% MHCV, June–July >20% but high base Oct–Nov last year (20–21% growth). Downside caution applied for Oct–Dec comparison.

Q1 LCV industry +17%. Ashok LCV +21%. Company gaining share (VAHAN +30 bps). H2 growth expected sustained at similar or higher rates.

RAK plant ramping to 800 units/month (from 600 cap; temp arrangements). No retail loss in GCC. New Saudi plant accelerating. Wholesale recovery dependent on geopolitical stabilization.

Based on supplier feedback, SIAM/CRISIL reports. Steel/rubber headwinds acknowledged as persistent. Exact magnitude of softening unquantified. Recovery assumption: Q3 onwards.

Cumulative price increases 2.25% MHCV, 3.5% LCV YTD. Achieve 2K cost-save project delivering unspecified benefits. Mix shift to HIPPO/TAURUS higher-margin trucks and non-MHCV (Defense, PSB) as levers.

Q1 EBITDA margin 10.1% (-100 bps YoY). No guidance for Q2–Q4 margin levels. Management states 'cannot tell exactly at this time'.

Already running at ₹900–1,000 Cr range in past 2 years. Focused on new products, EVs, alternate powertrain, white-space segments. Specific allocation between segments deferred.

GCC demand momentum strong despite geopolitical volatility. Company seeking to expedite plant commissioning. Timeline not revised with specifics.

Steel, natural rubber, other material costs elevated. Management estimates Q2 peak, Q3 softening, but supplier estimates uncertain. Commodity cost as % of revenue already 71.5% (+90 bps YoY). Further escalation risks margin collapse.

Management consumed 20–25% of Q1 costs from opening inventory (6,500→8,500 vehicles), deferring inflation to cost of goods. Inventory carrying ~₹80–100 Cr of deferred cost inflation. As vehicles sell in Q2–Q3, this cost hits P&L, amplifying margin compression.

Material costs +90 bps YoY to 71.5% of revenue. Cumulative price increases 2.25% MHCV, 3.5% LCV YTD are insufficient to offset inflation. Achieve 2K cost saves project not quantified. Q2 margin pressure may exceed mitigation capacity.

RAK (UAE) plant disrupted Apr–May 2026 due to war/logistics. Export volume -18% YoY in Q1. No retail losses claimed but wholesale stock reduction significant. Renewed escalation could suspend GCC operations again. New Saudi plant construction adds exposure.

LCV market share historically flat at ~11%. Company claims VAHAN share gain to 13.2% (+30 bps). New Saathi product targeting premium sub-2-ton. However, full LCV market (50% currently participated) is highly competitive; multi-product competitors (Tata, Mahindra, Force Motors) entrenched. Pipeline products unspecified.